Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis

Conclusions:
From the United Kingdom perspective, anidulafungin was cost-effective compared with fluconazole for the treatment of C/IC and was cost-saving versus the other echinocandins.

Source: BMC Infectious Diseases - October 26, 2015 Category: Infectious Diseases Authors: Georg AuzingerE. PlayfordChristopher GrahamHediyyih KnoxDavid WeinsteinMichal KanteckiHaran SchlammClaudie Charbonneau Source Type: research